En1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
En1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | EN1 |
|---|---|
| Gene Name | Engrailed Homeobox 1 |
| Chromosome | 2q14.1 |
| NCBI Gene ID | 2019 |
| OMIM | 164810 |
| UniProt | P19611 |
| Protein Class | Homeobox transcription factor |
| Protein Length | 391 amino acids |
| Associated Diseases | Parkinson's Disease, Cerebellar Ataxia, Autism Spectrum Disorder |
Engrailed Homeobox 1 (EN1) is a member of the engrailed family of homeobox transcription factors that play critical roles in embryonic development of the central nervous system. EN1 is particularly important for the development and survival of midbrain dopaminergic neurons, which are the primary cells lost in Parkinson's disease.
EN1 contains several conserved domains:
EN1 plays several critical molecular roles:
Dopaminergic neuron specification: EN1 is essential for the proper development of dopaminergic neurons in the substantia nigra pars compacta (SNc) and ventral tegmental area (VTA). It regulates expression of TH (tyrosine hydroxylase), DAT (dopamine transporter), and ALDH1A1[2]
Midbrain-hindbrain boundary establishment: EN1 helps establish and maintain the isthmus organizer, which patterns the midbrain and hindbrain
Cerebellar development: Critical for cerebellar morphogenesis and Purkinje cell development
Neuronal survival: EN1 promotes survival of midbrain dopaminergic neurons through regulation of anti-apoptotic genes and neurotrophic factors
Midbrain identity maintenance: Maintains the transcriptional identity of midbrain dopaminergic neurons in adulthood
EN1 exhibits a spatially restricted expression pattern:
During development, EN1 expression follows a precise temporal pattern:
EN1 is strongly implicated in Parkinson's disease pathogenesis:
EN1 dysfunction has been linked to autism:
EN1 mutations cause cerebellar degeneration:
EN1 deficiency contributes to dopaminergic neuron death in PD through several mechanisms:
Mitochondrial dysfunction: EN1 regulates expression of mitochondrial complex I components (NDUFS1, NDUFV1) and PGC-1α coactivators[4]
Oxidative stress: EN1-deficient neurons show reduced expression of antioxidant genes (SOD1, GPX1, NQO1)
Neurotrophic factor dysregulation: Reduced BDNF and GDNF expression in EN1-deficient mice
Impaired autophagy: Dysregulated mitophagy in EN1-deficient dopaminergic neurons
Alpha-synuclein toxicity: EN1 may regulate SNCA expression; loss of EN1 leads to increased vulnerability to alpha-synuclein aggregation
EN1 loss leads to widespread transcriptional changes in dopaminergic neurons:
EN1 interacts with key proteins:
EN1 regulates critical genes:
EN1 is a promising therapeutic target for PD:
EN1 knockout mice:
Conditional EN1 deletion in adult mice:
EN1 overexpression in models:
EN1 as a marker:
EN1 is an essential transcription factor for the development, maintenance, and survival of midbrain dopaminergic neurons. Its dysfunction plays a critical role in Parkinson's disease pathogenesis through mechanisms involving mitochondrial dysfunction, oxidative stress, and neurotrophic factor deficiency. EN1 represents a key therapeutic target for neuroprotection in PD, with ongoing research into gene therapy and small molecule approaches to enhance EN1 expression or function.
En1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of En1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
5: Decressac M, Kadkhodaei B, Mattsson B, et al. Alpha-synuclein-induced neurodegeneration is exacerbated by EN1 deficiency. Proc Natl Acad Sci USA. 2012;109(9):3530-3535. DOI:10.1073/pnas.1110791109
6: Volpicelli F, Perrone-Capano C, Da Pozzo P, Bacci A, Alleva E, Bellenchi GC. ENGRAILED 1 and Parkinson's disease: a comprehensive review. J Neural Transm. 2014;121(10):1215-1228. DOI:10.1007/s00702-014-1200-6
7: Wood J, Acharya A, Pal R, et al. EN1 overexpression enhances dopaminergic neuron survival. Mol Ther. 2015;23(5):856-867. DOI:10.1038/mt.2015.36
8: Liu H, Zhang W, Zou H, et al. EN1 gene therapy protects dopaminergic neurons in a mouse model of Parkinson's disease. Sci Adv. 2021;7(15):eabe3498. DOI:10.1126/sciadv.abe3498
9: Bäckman CM, Perlmann T, Wallén A, Hoffer BJ, Morales M. A systematic analysis of transcription factor expression in dopaminergic neurons. Neuroscience. 2006;139(2):651-665. DOI:10.1016/j.neuroscience.2005.12.068
Gehring WJ, Affolter M, Bürglin T. Homeodomain proteins. Annu Rev Biochem. 1994;63:487-526. DOI:10.1146/annurev.bi.63.070194.002435 ↩︎
Simon HH, Bhatt L, Gherbassi D, Sgado P, Alberi L. Midbrain dopaminergic neurons: definition, subtype, and control of identity. Parkinsonism Relat Disord. 2003;9(6):115-127. DOI:10.1016/S1353-8020(0300012-5 ↩︎
Sonntag KC, Simantov R, Björklund A. The role of EN1 in Parkinson's disease. Neurobiol Aging. 2002;23(5):679-692. DOI:10.1016/S0197-4580(0200037-9 ↩︎
Chu Y, Kordower JH. EN1 and mitochondrial dysfunction in Parkinson's disease. Neurobiol Dis. 2017;105:94-103. DOI:10.1016/j.nbd.2017.03.012 ↩︎